NOTICE: Due to a lapse in annual appropriations, most of this website is not being updated. Learn more.
Form submissions will still be accepted but will not receive responses at this time. Sections of this site for programs using non-appropriated funds (such as NVLAP) or those that are excepted from the shutdown (such as CHIPS and NVD) will continue to be updated.
An official website of the United States government
Here’s how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
In Vitro Studies for Detection of CYP27A1 Modifications with Iso[4]levuglandin E2 in Human Retina
Published
Author(s)
Illarion Turko, Casey Charvet, Wei-Li Liao, Gun-Young Heo, Laird James, Salomon G. Robert, Irina A. Pikuleva
Abstract
Isolevuglandins are highly reactive products of free radical-induced oxidation of arachidonates that modify free amino groups of proteins into pyrrole-derived adducts. These protein adducts provide a "footprint" of oxidative injury and are potential biomarkers for assessing risk for oxidative stress-associated diseases. Here, we used a multiple reaction monitoring (MRM) assay with 15N-labeled protein internal standards for detection and quantitative analysis of pyrrole, lactam, and hydroxylactam adducts of mitochondrial cytochrome P450, CYP27A1. In vitro modification of CYP27A1 with iso[4]LGE2 revealed a limited set of Lys residues susceptible to modification, including Lys358 and Lys476. Analysis of in vitro modified 15N-CYP27A1 revealed the most intense transitions and their intensity ratios for peptides having modified Lys358 and Lys476. This information was further used to detect the lactam and hydroxylactam adducts of CYP27A1 in human neural retina from a donor with dry age-related macular degeneration. Prior to MRM assay, the retina sample supplemented with modified 15NCYP27A1 was enriched in CYP27A1 content using a whole gel elution technique. The combination of MRM assay using 15N-labeled protein internal standard with enrichment of target protein(s) using whole gel elution can be adapted to analysis of other proteins which may be subject to modification in vivo.
Turko, I.
, Charvet, C.
, Liao, W.
, Heo, G.
, James, L.
, Robert, S.
and Pikuleva, I.
(2011),
In Vitro Studies for Detection of CYP27A1 Modifications with Iso[4]levuglandin E<sub>2</sub> in Human Retina, Analytical Chemistry, [online], https://tsapps.nist.gov/publication/get_pdf.cfm?pub_id=907265
(Accessed October 10, 2025)